Long-term hospital-based secondary prevention of coronary artery disease: a randomized controlled trial

Table 2 All-cause mortality, composite endpoint and total number of cardiovascular events in patients with and without hospital-based secondary preventive follow-up program after acute myocardial infarction (MI), percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG)

	Hospital-based follow-up	No hospital-based follow-up	p
	n = 788	n = 752
	n	n
All-cause mortality	33 (4%)	32 (4%)	0.86
Composite endpoint*	214 (27%)	235 (31%)	0.02
Myocardial infarction	38 (5%)	39 (5%)	0.56
Percutaneous coronary intervention	144 (18%)	179 (24%)	0.002
Coronary artery bypass grafting	11 (1%)	12 (2%)	0.71
Stroke	33 (4%)	30 (4%)	0.95

Mean follow-up time was 5.9 [SD 2.8] and 5.3 [SD 2.8] years in the group with and without hospital-based follow-up, respectively (p < 0.001)
*Composite endpoint consists of all-cause death, non-fatal myocardial infarction, new PCI/CABG or non-fatal stroke, the first event determining the end of follow-up in the composite endpoint-free survival analysis

ISSN: 1471-2261